PYXS

Pyxis Oncology Inc. Common Stock (PYXS)

Stock · NASDAQ · Health Care

$3.23as of 8/28/2026

Active signals

No technical signal is currently active for this symbol.

Support level
$1.66
Industry
Biotechnology: Pharmaceutical Preparations

How Pyxis Oncology Inc. Common Stock Makes Money

Where the revenue actually goes — FY2025 annual results

market-wall.comTotalRevenue$13.86MR&D$73.70M (532%)SG&A$22.19M (160%)Cost of Revenue$2.39M (17%)Tax$1.40M (10%)PYXS

Source: 10-K filed Mar 23, 2026 · via SEC EDGAR / Finnhub

Pyxis Oncology Inc. Common Stock Competitors

Chosen by industry and closest market cap.

  • PYXS
    Pyxis Oncology Inc. Common Stock
    $3.23
    ▼ 2.71%
    Market cap $192.60MP/E
  • IMUX
    Immunic Inc. Common Stock
    $15.4
    ▼ 5.52%
    Market cap $192.06MP/E
    $5.06$17.43
  • GLSI
    Greenwich LifeSciences Inc. Common Stock
    $15.67
    ▼ 16.34%
    Market cap $198.74MP/E
    $7.78$34.1
  • NBP
    NovaBridge Biosciences American Depositary Shares
    $1.85
    ▼ 2.38%
    Market cap $185.76MP/E
    $1.46$6.79
  • KROS
    Keros Therapeutics Inc. Common Stock
    $11.05
    ▼ 1.60%
    Market cap $200.10MP/E
    $9.69$22.55
  • MSLE
    Satellos Bioscience Inc. Common Stock
    $8.92
    ▼ 7.23%
    Market cap $203.94MP/E
    $7.08$18.98
  • WHWK
    Whitehawk Therapeutics Inc. Common Stock
    $4.65
    ▼ 4.52%
    Market cap $212.98MP/E
    $1.76$5.5

P/E shows — for peers not currently carrying a live signal of their own.

Institutional Ownership

March 31, 2026

Total shares held
27.37M
Total value held
$40.01M
Institutional holders
74
Top holders this quarter
  • Unknown7.03M
  • Unknown5.00M
  • Unknown4.12M
  • Unknown2.03M
  • Unknown1.01M
  • Unknown896.3K
  • Unknown888.7K
  • Unknown788.8K
  • Unknown598.1K
  • Unknown503.2K

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.